(Q84646073)

English

MAGRIT: the largest-ever phase III lung cancer trial aims to establish a novel tumor-specific approach to therapy

scientific article published on 01 September 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19808198

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19808198%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 February 2020

title

MAGRIT: the largest-ever phase III lung cancer trial aims to establish a novel tumor-specific approach to therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19808198

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19808198%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 February 2020

main subject

phase III clinical trial

1 reference

1 reference

Preeta Tyagi

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19808198

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19808198%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 February 2020

Beloo Mirakhur

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19808198

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19808198%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 February 2020

publication date

1 September 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19808198

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19808198%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

19808198

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19808198%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 February 2020

volume

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19808198

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19808198%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 February 2020

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19808198

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19808198%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 February 2020

page(s)

371-374

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19808198

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19808198%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 February 2020

Identifiers

DOI

10.3816/CLC.2009.N.052

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19808198

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19808198%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 February 2020

PubMed publication ID

19808198

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19808198

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19808198%20AND%20SRC:MED&resulttype=core&format=json

(Q84646073)

MAGRIT: the largest-ever phase III lung cancer trial aims to establish a novel tumor-specific approach to therapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)